PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
GSK vs. NGG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GSK and NGG is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.4

Performance

GSK vs. NGG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GlaxoSmithKline plc (GSK) and National Grid plc (NGG). The values are adjusted to include any dividend payments, if applicable.

100.00%200.00%300.00%400.00%500.00%600.00%700.00%NovemberDecember2025FebruaryMarchApril
118.19%
703.47%
GSK
NGG

Key characteristics

Sharpe Ratio

GSK:

-0.11

NGG:

0.60

Sortino Ratio

GSK:

0.01

NGG:

0.89

Omega Ratio

GSK:

1.00

NGG:

1.14

Calmar Ratio

GSK:

-0.10

NGG:

0.73

Martin Ratio

GSK:

-0.19

NGG:

1.61

Ulcer Index

GSK:

15.39%

NGG:

9.45%

Daily Std Dev

GSK:

24.92%

NGG:

25.49%

Max Drawdown

GSK:

-55.21%

NGG:

-54.85%

Current Drawdown

GSK:

-12.05%

NGG:

0.00%

Fundamentals

Market Cap

GSK:

$79.23B

NGG:

$67.96B

EPS

GSK:

$1.61

NGG:

$2.64

PE Ratio

GSK:

24.23

NGG:

26.28

PEG Ratio

GSK:

0.39

NGG:

2.18

Total Revenue (TTM)

GSK:

$24.01B

NGG:

$7.96B

Gross Profit (TTM)

GSK:

$16.98B

NGG:

$7.96B

EBITDA (TTM)

GSK:

$5.14B

NGG:

$2.42B

Returns By Period

The year-to-date returns for both investments are quite close, with GSK having a 16.61% return and NGG slightly higher at 16.78%. Over the past 10 years, GSK has underperformed NGG with an annualized return of 2.96%, while NGG has yielded a comparatively higher 7.20% annualized return.


GSK

YTD

16.61%

1M

1.51%

6M

3.96%

1Y

-2.27%

5Y*

5.22%

10Y*

2.96%

NGG

YTD

16.78%

1M

11.26%

6M

5.32%

1Y

15.01%

5Y*

13.41%

10Y*

7.20%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

GSK vs. NGG — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GSK
The Risk-Adjusted Performance Rank of GSK is 4646
Overall Rank
The Sharpe Ratio Rank of GSK is 4848
Sharpe Ratio Rank
The Sortino Ratio Rank of GSK is 4141
Sortino Ratio Rank
The Omega Ratio Rank of GSK is 4141
Omega Ratio Rank
The Calmar Ratio Rank of GSK is 4848
Calmar Ratio Rank
The Martin Ratio Rank of GSK is 5050
Martin Ratio Rank

NGG
The Risk-Adjusted Performance Rank of NGG is 7373
Overall Rank
The Sharpe Ratio Rank of NGG is 7676
Sharpe Ratio Rank
The Sortino Ratio Rank of NGG is 6565
Sortino Ratio Rank
The Omega Ratio Rank of NGG is 6969
Omega Ratio Rank
The Calmar Ratio Rank of NGG is 8181
Calmar Ratio Rank
The Martin Ratio Rank of NGG is 7272
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GSK vs. NGG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for GlaxoSmithKline plc (GSK) and National Grid plc (NGG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for GSK, currently valued at -0.11, compared to the broader market-2.00-1.000.001.002.003.00
GSK: -0.11
NGG: 0.60
The chart of Sortino ratio for GSK, currently valued at 0.01, compared to the broader market-6.00-4.00-2.000.002.004.00
GSK: 0.01
NGG: 0.89
The chart of Omega ratio for GSK, currently valued at 1.00, compared to the broader market0.501.001.502.00
GSK: 1.00
NGG: 1.14
The chart of Calmar ratio for GSK, currently valued at -0.10, compared to the broader market0.001.002.003.004.005.00
GSK: -0.10
NGG: 0.73
The chart of Martin ratio for GSK, currently valued at -0.19, compared to the broader market-10.00-5.000.005.0010.0015.0020.00
GSK: -0.19
NGG: 1.61

The current GSK Sharpe Ratio is -0.11, which is lower than the NGG Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of GSK and NGG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00NovemberDecember2025FebruaryMarchApril
-0.11
0.60
GSK
NGG

Dividends

GSK vs. NGG - Dividend Comparison

GSK's dividend yield for the trailing twelve months is around 3.98%, less than NGG's 10.12% yield.


TTM20242023202220212020201920182017201620152014
GSK
GlaxoSmithKline plc
3.98%4.60%3.75%4.78%4.92%5.49%4.28%5.55%5.72%7.06%5.96%6.09%
NGG
National Grid plc
10.12%11.81%5.20%5.13%4.71%5.29%4.90%6.44%24.15%5.07%4.73%7.86%

Drawdowns

GSK vs. NGG - Drawdown Comparison

The maximum GSK drawdown since its inception was -55.21%, roughly equal to the maximum NGG drawdown of -54.85%. Use the drawdown chart below to compare losses from any high point for GSK and NGG. For additional features, visit the drawdowns tool.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-12.05%
0
GSK
NGG

Volatility

GSK vs. NGG - Volatility Comparison

The current volatility for GlaxoSmithKline plc (GSK) is 6.83%, while National Grid plc (NGG) has a volatility of 7.83%. This indicates that GSK experiences smaller price fluctuations and is considered to be less risky than NGG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%5.00%6.00%7.00%8.00%9.00%10.00%11.00%NovemberDecember2025FebruaryMarchApril
6.83%
7.83%
GSK
NGG

Financials

GSK vs. NGG - Financials Comparison

This section allows you to compare key financial metrics between GlaxoSmithKline plc and National Grid plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab